1
|
Barbosa MS, Sampaio BA, Spergser J, Rosengarten R, Marques LM, Chopra-Dewasthaly R. Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies. Vaccines (Basel) 2024; 12:156. [PMID: 38400139 PMCID: PMC10892753 DOI: 10.3390/vaccines12020156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 01/26/2024] [Accepted: 01/31/2024] [Indexed: 02/25/2024] Open
Abstract
Contagious agalactia (CA) is a serious multietiological disease whose classic etiological agent is Mycoplasma agalactiae and which causes high morbidity and mortality rates in infected herds. CA is classified as a notifiable disease by the World Organization for Animal Health due to its significant worldwide economic impact on livestock, primarily involving goat and sheep farms. The emergence of atypical symptoms and strains of M. agalactiae in wildlife ungulates reestablishes its highly plastic genome and is also of great epidemiological significance. Antimicrobial therapy is the main form of control, although several factors, such as intrinsic antibiotic resistance and the selection of resistant strains, must be considered. Available vaccines are few and mostly inefficient. The virulence and pathogenicity mechanisms of M. agalactiae mainly rely on surface molecules that have direct contact with the host. Because of this, they are essential for the development of vaccines. This review highlights the currently available vaccines and their limitations and the development of new vaccine possibilities, especially considering the challenge of antigenic variation and dynamic genome in this microorganism.
Collapse
Affiliation(s)
- Maysa Santos Barbosa
- Department of Biointeraction, Multidisciplinary Institute of Health, Federal University of Bahia, Vitoria da Conquista 45029-094, Brazil; (M.S.B.)
| | | | - Joachim Spergser
- Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Wien, Austria
| | - Renate Rosengarten
- Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Wien, Austria
| | - Lucas Miranda Marques
- Department of Biointeraction, Multidisciplinary Institute of Health, Federal University of Bahia, Vitoria da Conquista 45029-094, Brazil; (M.S.B.)
- Department of Microbiology, State University of Santa Cruz (UESC), Ilheus 45662-900, Brazil
- Department of Microbiology, Institute of Biomedical Science, University of São Paulo, Sao Paulo 05508-000, Brazil
| | - Rohini Chopra-Dewasthaly
- Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Wien, Austria
| |
Collapse
|
2
|
Eating the Enemy: Mycoplasma Strategies to Evade Neutrophil Extracellular Traps (NETs) Promoting Bacterial Nucleotides Uptake and Inflammatory Damage. Int J Mol Sci 2022; 23:ijms232315030. [PMID: 36499356 PMCID: PMC9740415 DOI: 10.3390/ijms232315030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Revised: 11/22/2022] [Accepted: 11/28/2022] [Indexed: 12/05/2022] Open
Abstract
Neutrophils are effector cells involved in the innate immune response against infection; they kill infectious agents in the intracellular compartment (phagocytosis) or in the extracellular milieu (degranulation). Moreover, neutrophils release neutrophil extracellular traps (NETs), complex structures composed of a scaffold of decondensed DNA associated with histones and antimicrobial compounds; NETs entrap infectious agents, preventing their spread and promoting their clearance. NET formation is triggered by microbial compounds, but many microorganisms have evolved several strategies for NET evasion. In addition, the dysregulated production of NETs is associated with chronic inflammatory diseases. Mycoplasmas are reduced genome bacteria, able to induce chronic infections with recurrent inflammatory symptoms. Mycoplasmas' parasitic lifestyle relies on metabolite uptake from the host. Mycoplasmas induce NET release, but their surface or secreted nucleases digest the NETs' DNA scaffold, allowing them to escape from entrapment and providing essential nucleotide precursors, thus promoting the infection. The presence of Mycoplasma species has been associated with chronic inflammatory disorders, such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, and cancer. The persistence of mycoplasma infection and prolonged NET release may contribute to the onset of chronic inflammatory diseases and needs further investigation and insights.
Collapse
|
3
|
Preliminary Study on the Host Response to Bivalent and Monovalent Autogenous Vaccines against Mycoplasma agalactiae in Dairy Sheep. Vet Sci 2022; 9:vetsci9120651. [PMID: 36548812 PMCID: PMC9785335 DOI: 10.3390/vetsci9120651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 11/15/2022] [Accepted: 11/17/2022] [Indexed: 11/24/2022] Open
Abstract
In Italy, dairy sheep farming represents a vital agro-industry sector, but it is still challenged by contagious agalactia (CA), which is endemic there, and vaccination is the most economical and sustainable tool for control. This study aimed to evaluate the combined Mycoplasma agalactiae (Ma)-Staphylococcus aureus (Sa) vaccine (Ma-Sa) against the Ma monovalent vaccine in ewes. Twelve primiparous Ma-free ewes were randomly grouped into three equal groups: first, the control group injected with placebo, second, the group vaccinated with the Ma monovalent vaccine, and third, the group vaccinated with Ma-Sa combined vaccine, with two S/C doses at 45-day intervals. The animals were examined for serological, hematological, and somatic cell count (SCC) changes for 17 successive weeks. A significant increase in anti-Ma antibody mean titers, leukocytes, and platelets was observed in the vaccinated animals, with the highest values in those who received the combined vaccine. Neutrophils were high only in the animals who received the combined vaccine. SCC was lower in the vaccinated animals during the first six weeks. This study concludes that the combined Ma-Sa vaccines enhance immune response and potentiate its efficacy against Ma. This improvement might be attributed to the sensitization/activation effect of S. aureus on platelets, which are recoded to act as a key regulator for the coordination of all components of the innate immune system. Even though this study included a small number of animals, its findings about the potentialities of this inactivated vaccine in the control of CA are strongly encouraging. Further confirmation might be needed through additional replicates and a challenge study is needed before proceeding with widespread use.
Collapse
|
4
|
Influence of natural and climatic conditions on the distribution and forms of contagious agalactia in sheep in Bessarabia, Ukraine. J Vet Res 2022; 66:345-351. [PMID: 36349124 PMCID: PMC9597942 DOI: 10.2478/jvetres-2022-0047] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 08/22/2022] [Indexed: 11/21/2022] Open
Abstract
Abstract
Introduction
Contagious agalactia of ruminants is an endemic disease caused by Mycoplasma agalactiae in flicting significant losses on farms in deaths and forced slaughter of sick animals, abortions, births of sick young animals, and reduced milk and wool production. The aim of the study was to determine the influence of hydrometeorological conditions on the distribution and forms of contagious agalactia in sheep in Bessarabia, Ukraine.
Material and Methods
The epizootic situation regarding contagious agalactia was studied during 2011–2021 on sheep farms in the south of the Odesa region in Bessarabia. Over two million blood samples from sheep aged 1–6 years were serologically investigated and the prevalence of agalactia was correlated with Selyaninov’s hydrothermal coefficient for each sampling year.
Results
High rates of infection of sheep with contagious agalactia (from 13.1% to 14.4%) were registered in 2012, 2016 and 2021, years which according to the hydrothermal coefficient of 1.0 were sufficiently moist. The lowest incidence rates, from 6.5% to 7.4%, were registered in the very dry 2013, 2014 and 2019 with hydrothermal coefficients of 0.5‒0.6. In sufficiently moist years, contagious agalactia of sheep manifested itself in the mastitic form, while in the dry period the mastitic form was half as prevalent, and the mixed, articular and ocular forms of the disease proliferated.
Conclusion
The results indicate the circulation of Mycoplasma agalactiae among small ruminants in Bessarabia, and that the prevalence and the course of the associated disease depend on the humidity of the climate, i.e. the value of the hydrothermal coefficient.
Collapse
|
5
|
Abdollahi M, Lotfollahzadeh S, Salehi TZ, Moosakhani F, Raoofi A. Assessment of the duration of maternal‐derived antibodies specific to the
Mycoplasma agalactiae
vaccine in goat kids. Vet Med Sci 2022; 8:2119-2125. [PMID: 35852213 PMCID: PMC9514469 DOI: 10.1002/vms3.888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Background Contagious agalactia (CA) is one of the most important diseases in the small ruminant industry in Iran. The historical aetiology of this disease is Mycoplasma agalactiae (Ma). The main way to control this disease, in addition to management measures, is vaccination. In ruminant newborns, determining the age of first vaccination against Ma is a challenge due to the interference between colostrum‐derived maternal immunity and vaccination‐induced immunity. The aim of this study was to evaluate the consistency of maternal‐derived antibodies specific to the Ma in goat kids blood serum born from the vaccinated does. Objectives Dtermination of level of antibody against Ma in goat kids born from vaccinated dams against Ma. Assessment of duration of protective level of maternal derived antibody in goat kids serum, after receiving colostrum from vaccinted mother with Ma vaccine. Determination the best time vaccination against Ma in goat kids receiving colostrum from vaccinated dams. Methods 20 Saanen goat kids were studied in two groups of 10 animals including control (receiving colostrum from unvaccinated does) and treatment (receiving colostrum from vaccinated does). Indirect Elisa was used to evaluate serum specific antibodies to Ma in goat kids (control and treatment groups) from birth to 100 days of age. Results After receiving a sufficient amount of colostrum, the goat kids in the treatment group had a significantly higher S/P% than the control group until 56 days after birth (p < 0.05) and at 70–100 days after birth, there was no significant difference between the treatment and control groups (p > 0.05). Conclusions This study showed that 56–70 days of age could be a good age to give the first dose of CA vaccine in goat kids, but more studies are needed on the effectiveness of this vaccine at this age.
Collapse
Affiliation(s)
- Mostafa Abdollahi
- Faculty of Veterinary Medicine Departmnent of Internal Medicine University of Tehran Tehran Iran
| | - Samad Lotfollahzadeh
- Faculty of Veterinary Medicine Departmnent of Internal Medicine University of Tehran Tehran Iran
| | - Taghi Zahraei Salehi
- Faculty of Veterinary Medicine Department of Microbiology and Immunology University of Tehran Tehran Iran
| | - Farhad Moosakhani
- Faculty of Veterinary Medicine Department of Microbiology and Immunology Islamic Azad University Karaj Branch Karaj Iran
| | - Afshin Raoofi
- Faculty of Veterinary Medicine Departmnent of Internal Medicine University of Tehran Tehran Iran
| |
Collapse
|
6
|
Sheep Infection Trials with 'Phase-Locked' Vpma Expression Variants of Mycoplasma agalactiae-Towards Elucidating the Role of a Multigene Family Encoding Variable Surface Lipoproteins in Infection and Disease. Microorganisms 2022; 10:microorganisms10040815. [PMID: 35456865 PMCID: PMC9025108 DOI: 10.3390/microorganisms10040815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Revised: 03/27/2022] [Accepted: 04/12/2022] [Indexed: 11/30/2022] Open
Abstract
The significance of large multigene families causing high-frequency surface variations in mycoplasmas is not well-understood. Previously, VpmaY and VpmaU clonal variants of the Vpma family of lipoproteins of M. agalactiae were compared via experimental sheep infections using the two corresponding ‘Phase-Locked Mutants’. However, nothing is known about the infectivity of the remaining four Vpma expression variants VpmaX, VpmaW, VpmaZ and VpmaV as they were never evaluated in vivo. Here, in vivo infection and disease progression of all six Vpma expressers constituting the Vpma family of type strain PG2 were compared using the corresponding xer1-disrupted PLMs expressing single well-characterized Vpmas. Each of the six PLMs were separately evaluated using the intramammary sheep infection model along with the control phase-variable wildtype strain PG2. Thorough bacteriological, pathological and clinical examinations were performed, including assessment of milk quality, quantity and somatic cell counts. Altogether, the results indicated that the inability to vary the Vpma expression phase does not hamper the initiation of infection leading to mastitis for all six PLMs, except for PLMU, which showed a defect in host colonization and multiplication for the first 24 h p.i. and pathological/bacteriological analysis indicated a higher potential for systemic spread for PLMV and PLMX. This is the first study in which all isogenic expression variants of a large mycoplasma multigene family are tested in the natural host.
Collapse
|
7
|
Predominant Single Stable VpmaV Expression in Strain GM139 and Major Differences with Mycoplasma agalactiae Type Strain PG2. Animals (Basel) 2022; 12:ani12030265. [PMID: 35158589 PMCID: PMC8833448 DOI: 10.3390/ani12030265] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 01/12/2022] [Accepted: 01/17/2022] [Indexed: 01/27/2023] Open
Abstract
Simple Summary MALDI-ToF MS analysis demonstrates major differences between Mycoplasma agalactiae type strain PG2 and strain GM139. Evaluation of the Vpma (variable proteins of M. agalactiae) phenotypic profiles of these two strains reveals that unlike PG2, GM139 expresses a single Vpma, namely VpmaV, and without any visible phase variation. Although the presence of only one Vpma seems to be sufficient for the pathogenesis of the GM139 strain, the absence of phase variation can compromise immune system evasion and spread to other anatomical sites in the host. Abstract Although mycoplasmas have a reduced genome and no cell wall, they have important mechanisms for the antigenic variation in surface lipoproteins that modulate their interactions with the host. Mycoplasma agalactiae, the main etiological agent of contagious agalactia, has a multigene family involved in the high-frequency phase variation in surface lipoproteins called variable proteins of M. agalactiae (Vpmas). The Vpma lipoproteins are involved in the immune evasion, colonization, dissemination, and persistence of M. agalactiae in the host. In this paper, we evaluate the Vpma phenotypic profiles of two different strains of M. agalactiae, namely, GM139 and the type strain PG2, to assess possible correlations between Vpma phase variability and the geographic localization, animal origin, and pathogenicity of these two strains. Using monospecific Vpma antibodies against individual Vpmas in immunoblots, we demonstrate that, unlike PG2, which expresses six Vpma proteins with high-frequency phase variation, colonies of GM139 predominantly express VpmaV and do not exhibit any sectoring phenotype for any Vpma. Since VpmaV is one of the most important Vpmas for cell adhesion and invasion, its predominant sole expression in GM139 without high-frequency variation may be the basis of the differential pathogenicity of GM139 and PG2. Additionally, MALDI-ToF MS analysis also demonstrates significant differences between these two strains and their relatedness with other M. agalactiae strains.
Collapse
|
8
|
Vaccines for Mycoplasma Diseases of Small Ruminants: A Neglected Area of Research. Pathogens 2022; 11:pathogens11010075. [PMID: 35056023 PMCID: PMC8781016 DOI: 10.3390/pathogens11010075] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2021] [Revised: 12/23/2021] [Accepted: 01/04/2022] [Indexed: 02/06/2023] Open
Abstract
Mycoplasmas cause some of the most economically important diseases of sheep and goats, including diseases listed by the World Organisation for Animal Health (OIE) such as contagious caprine pleuropneumonia (CCPP) and contagious agalactia (CA). Other important mycoplasma diseases include chronic respiratory and arthritic syndrome (CRAS) and atypical pneumonia, both present on all continents where small ruminants are farmed. Unfortunately, owing to a lack of investment, most commercial vaccines for these diseases are of poor quality, being mostly composed of killed bacteriocins of dubious or unknown efficacy. Several Mediterranean laboratories produce autogenous vaccines, but these can only be used on farms where outbreaks have been officially declared, and consequently have limited impact on disease nationally. Effective live vaccines are available, but their use is often restricted because of safety concerns. With the necessary safeguards in place, we argue for their greater use. This review examines reported vaccines for mycoplasma diseases of small ruminants and attempts to identify new candidate antigens that may enable the development of improved products. Vaccines for CCPP are covered elsewhere.
Collapse
|
9
|
Galluzzo P, Migliore S, Puleio R, Galuppo L, La Russa F, Blanda V, Tumino S, Torina A, Ridley A, Loria GR. Detection of Mycoplasma agalactiae in Ticks ( Rhipicephalus bursa) Collected by Sheep and Goats in Sicily (South-Italy), Endemic Area for Contagious Agalactia. Microorganisms 2021; 9:microorganisms9112312. [PMID: 34835438 PMCID: PMC8625260 DOI: 10.3390/microorganisms9112312] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/03/2021] [Accepted: 11/05/2021] [Indexed: 11/16/2022] Open
Abstract
The aim of this preliminary study was to investigate the presence of Mycoplasma agalactiae (Ma) or other Contagious Agalactia (CA) causative organisms, in hard ticks infesting milking sheep and goats in endemic areas for CA in Sicily (South-Italy). Although there is accumulating evidence to support the role of ticks in the transmission of blood-borne haemoplasmas, information regarding their role in the transmission of CA, remains scarce. Ticks (n = 152) were collected from 25 lactating sheep and goats from three farms with previous outbreaks of CA. Microbiological and biomolecular, as well as serological analysis were performed on milk, tick, and serum samples, respectively. Rhipicephalus bursa species predominated, comprising 84.8% of the sampled ticks. Mycoplasma-like colonies were isolated from 5/56 (8.9%) tick pools and were identified as Ma by specific PCR and 16S rRNA gene sequencing. Unexpectedly, the organism was isolated from R. bursa ticks recovered only from animals whose milk tested negative for the pathogen. This preliminary demonstration suggests the potential role for ticks to act as a reservoir for the organisms, with potential involvement in the spread and maintenance of CA. Further work is required to determine the location of the organisms within the body of the ticks and to assess transmission potential.
Collapse
Affiliation(s)
- Paola Galluzzo
- OIE Reference Laboratory for Contagious Agalactia, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (P.G.); (R.P.); (L.G.); (S.T.); (G.R.L.)
- Dipartimento Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, University of Palermo, Viale delle Scienze, 90128 Palermo, Italy
| | - Sergio Migliore
- OIE Reference Laboratory for Contagious Agalactia, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (P.G.); (R.P.); (L.G.); (S.T.); (G.R.L.)
- Correspondence: ; Tel.: +39-0916565307
| | - Roberto Puleio
- OIE Reference Laboratory for Contagious Agalactia, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (P.G.); (R.P.); (L.G.); (S.T.); (G.R.L.)
| | - Lucia Galuppo
- OIE Reference Laboratory for Contagious Agalactia, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (P.G.); (R.P.); (L.G.); (S.T.); (G.R.L.)
| | - Francesco La Russa
- Entomology Laboratory, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (F.L.R.); (V.B.); (A.T.)
| | - Valeria Blanda
- Entomology Laboratory, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (F.L.R.); (V.B.); (A.T.)
| | - Serena Tumino
- OIE Reference Laboratory for Contagious Agalactia, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (P.G.); (R.P.); (L.G.); (S.T.); (G.R.L.)
| | - Alessandra Torina
- Entomology Laboratory, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (F.L.R.); (V.B.); (A.T.)
| | - Anne Ridley
- Department of Bacteriology, OIE Reference Centre for Contagious Agalactia, Animal and Plant Health Agency, Addlestone KT15 3NB, Surrey, UK;
| | - Guido R. Loria
- OIE Reference Laboratory for Contagious Agalactia, Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi, 3, 90129 Palermo, Italy; (P.G.); (R.P.); (L.G.); (S.T.); (G.R.L.)
| |
Collapse
|